点眼剤市場：種類別、治療用途別、薬剤クラス別、防腐剤別、種類別、剤型別、粘度別、流通チャネル別、エンドユーザー別、地域別

点眼剤市場は2025年に68億1,000万米ドルと推定され、2032年には92億7,000万米ドルに達すると予測され、2025年から2032年までの年間平均成長率（CAGR）は4.2%で成長する見込みです。

世界の点眼剤（目薬）市場は、眼科医薬品産業の重要なセグメントであり、さまざまな眼疾患に対処し、眼の健康を最適に維持するために設計された多様な治療・診断ソリューションを包含しています。

点眼液としても知られる点眼剤は、緑内障、ドライアイ症候群、アレルギー性結膜炎、細菌・ウイルス感染症、炎症関連疾患などを対象とする薬剤の主要な送達メカニズムとして機能します。この市場には、処方薬、市販薬、人工涙液、抗ヒスタミン薬、抗生物質、抗炎症薬、緑内障治療薬などの特殊製剤が含まれます。

人口の高齢化、長時間のスクリーン使用、環境汚染物質、ライフスタイルの変化などの要因によって眼に関連する疾患の有病率が高まる中、効果的な眼科治療に対する需要は世界的に拡大し続けています。市場の成長軌道は、ドラッグデリバリーシステムの技術的進歩、革新的な防腐剤フリーの製剤、患者のコンプライアンスと治療効果を高める徐放性メカニズムの開発によってさらに支えられています。

市場力学

世界の点眼剤市場は、国際市場での拡大を後押しするいくつかの主要要因によって支えられています。特に、緑内障、黄斑変性症、糖尿病性網膜症などの加齢に関連する疾患は、高齢化が進むにつれて世界中で数百万人が罹患しています。さらに、デジタル機器の使用頻度が急激に増加したことで、コンピューター視覚症候群やドライアイの症状が急増し、潤滑点眼剤や治療点眼剤に対する大きな需要が生まれています。

防腐剤フリーの製剤や徐放性メカニズムなど、ドラッグデリバリーシステムにおける技術革新は、患者のコンプライアンスと治療成績を向上させ、市場の成長をさらに後押ししています。しかし、市場拡大の可能性を阻む大きな要因もあります。眼科用製品に対する厳しい規制要件により、大規模な臨床試験と承認プロセスが必要となり、その結果、開発期間が長期化し、多額の財政投資が必要となるため、中小メーカーにとっては足かせとなりかねないです。

さらに、点眼剤に含まれる特定の防腐剤による汚染や副作用のリスクは、患者や医療従事者の間で安全性への懸念を高めています。また、大手ブランド製品の特許切れも競争圧力を強め、製薬会社の利益率を低下させています。このような課題にもかかわらず、市場には成長とイノベーションの大きな機会があります。また、アジア太平洋やラテンアメリカの新興市場は、医療インフラの改善や目の健康に対する意識の高まりにより、未開拓の可能性を秘めています。

当レポートの主な特徴

• 当レポートは、世界の点眼剤市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模・CAGRを掲載しています。
• また、各セグメントの潜在的な収益機会を明らかにし、この市場の魅力的な投資提案のマトリックスについて説明しています。
• また、市場の促進要因・抑制要因や機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 世界の点眼剤市場における主要企業プロファイルを、企業概要、製品ポートフォリオ、主要なハイライト、財務実績、戦略などの以下のパラメータに基づいて掲載しています。
• 当レポートの洞察を用いて、マーケティング担当者や企業の経営陣が、将来の製品発売・提携・市場拡大・マーケティング戦術に関する、十分な情報に基づいた意思決定を下すことができます。
• 「世界の点眼剤市場」レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界のさまざまな利害関係者に対応しています。
• 利害関係者は、世界の点眼剤市場の分析に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 分析目的と前提条件

• 分析目的
• 前提条件
• 略語

第2章 市場の展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー

第3章 市場力学・規制・動向分析

• 市場力学
• 促進要因
• 抑制要因
• 機会
• 影響分析
• 主な発展
• 規制シナリオ
• 製品の発売/承認
• PEST分析
• PORTERの分析
• 企業合併・買収 (M&A) のシナリオ
• 業界動向

第4章 世界の点眼剤市場：種類別（2020～2032年）

• 処方箋点眼剤
• 市販の点眼剤

第5章 世界の点眼剤市場、治療用途別（2020～2032年）

• ドライアイ（DED）の管理
• アレルギー性結膜炎の治療
• 緑内障と高眼圧症
• 眼感染症の治療（細菌性、ウイルス性、真菌性）
• 炎症または術後ケア
• 散瞳または毛様体麻痺
• 診断用染料溶液
• 術後ケア（点眼麻酔）
• ぶどう膜炎
• その他の網膜疾患

第6章 世界の点眼剤市場：薬剤クラス別（2020～2032年）

• 潤滑剤とエモリエント剤
• 抗ヒスタミン薬
• 肥満細胞安定剤
• コルチコステロイド
• 非ステロイド性抗炎症薬（NSAID）
• プロスタグランジン類似体
• ベータ遮断薬
• アルファ作動薬
• 炭酸脱水酵素阻害剤
• 抗生物質
• 抗ウイルス薬
• 抗真菌薬
• 血管収縮薬
• 併用薬

第7章 世界の点眼剤市場：防腐剤別（2020～2032年）

• 防腐剤入り点眼剤
• 防腐剤無し点眼剤

第8章 世界の点眼剤市場：種類別（2020～2032年）

• ブランド
• ジェネリック医薬品

第9章 世界の点眼剤市場：剤形別（2020～2032年）

• 溶液
• 懸濁液
• 乳剤

第10章 世界の点眼剤市場：粘度別（2020～2032年）

• 低粘度
• 中粘度
• 高粘度

第11章 世界の点眼剤市場：流通チャネル別（2020～2032年）

• 病院薬局
• 小売薬局
• オンライン薬局

第12章 世界の点眼剤市場：エンドユーザー別（2020～2032年）

• 病院
• 眼科クリニック
• その他（外来手術センター）

第13章 世界の点眼剤市場：地域別（2020～2032年）

• 北米
  • 米国
  • カナダ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
  • その他ラテンアメリカ
• 欧州
  • ドイツ
  • 英国
  • スペイン
  • フランス
  • イタリア
  • ロシア
  • その他欧州
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • 韓国
  • ASEAN
  • その他アジア太平洋
• 中東
  • GCC諸国
  • イスラエル
  • その他中東
• アフリカ
  • 南アフリカ
  • 北アフリカ
  • 中央アフリカ

第14章 競合情勢

• Alcon
• AbbVie Inc（Allergan）
• Bausch Health Companies Inc
• Johnson & Johnson Vision
• Santen Pharmaceutical Co Ltd
• Pfizer Inc
• Bayer AG
• Sun Pharmaceutical Industries Ltd
• Otsuka Pharmaceutical Co Ltd
• Rohto Pharmaceutical Co Ltd
• Thea Pharma Inc
• Similasan Corporation
• Akorn Operating Company LLC
• Prestige Consumer Healthcare Inc
• Jamjoom Pharmaceuticals

第15章 アナリストの提言

• 「運命の輪」
• アナリストの見解
• Coherent Opportunity Map (COM)

第16章 参考文献と調査手法

• 参考文献
• 分析手法
• Coherent Market Insightsについて

Eye Drops Market is estimated to be valued at USD 6.81 Bn in 2025 and is expected to reach USD 9.27 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032.

The global eye drops market represents a critical segment of the ophthalmic pharmaceutical industry, encompassing a diverse range of therapeutic and diagnostic solutions designed to address various ocular conditions and maintain optimal eye health.

Eye drops, also known as ophthalmic solutions, serve as the primary delivery mechanism for medications targeting conditions such as glaucoma, dry eye syndrome, allergic conjunctivitis, bacterial and viral infections, and inflammation-related disorders. The market encompasses prescription medications, over-the-counter solutions, and specialized formulations including artificial tears, antihistamines, antibiotics, anti-inflammatory agents, and glaucoma medications.

With the increasing prevalence of eye-related disorders driven by factors such as aging populations, prolonged screen time, environmental pollutants, and lifestyle changes, the demand for effective ophthalmic treatments continues to escalate globally. The market's growth trajectory is further supported by technological advancements in drug delivery systems, innovative preservative-free formulations, and the development of sustained-release mechanisms that enhance patient compliance and therapeutic efficacy.

Market Dynamics

The global eye drops market is propelled by several key drivers that collectively fuel its expansion across international markets. The primary growth driver stems from the rising prevalence of ocular disorders, particularly age-related conditions such as glaucoma, macular degeneration, and diabetic retinopathy, which affect millions of individuals worldwide as populations continue to age. Additionally, the exponential increase in digital device usage has led to a surge in computer vision syndrome and dry eye conditions, creating substantial demand for lubricating and therapeutic eye drops.

Technological innovations in drug delivery systems, including preservative-free formulations and extended-release mechanisms, enhance patient compliance and treatment outcomes, further driving market growth. However, the market faces significant restraints that challenge its expansion potential. Stringent regulatory requirements for ophthalmic products necessitate extensive clinical trials and approval processes, resulting in lengthy development timelines and substantial financial investments that may deter smaller manufacturers.

Furthermore, the risk of contamination and adverse reactions associated with certain preservatives in eye drops raises safety concerns among patients and healthcare providers. Patent expirations of major branded products also intensify competitive pressures and reduce profit margins for pharmaceutical companies. Despite these challenges, the market presents substantial opportunities for growth and innovation. The expanding geriatric population globally creates a sustained demand for ophthalmic treatments, while emerging markets in Asia Pacific and Latin America offer untapped potential due to improving healthcare infrastructure and rising awareness about eye health.

Key Features of the Study

• This report provides in-depth analysis of the global eye drops market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global eye drops market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include major pharmaceutical manufacturers, Alcon, AbbVie Inc (Allergan), Bausch Health Companies Inc, Johnson & Johnson Vision, Santen Pharmaceutical Co Ltd, Pfizer Inc, Bayer AG, Sun Pharmaceutical Industries Ltd, Otsuka Pharmaceutical Co Ltd, Rohto Pharmaceutical Co Ltd, Thea Pharma Inc, Similasan Corporation, Akorn Operating Company LLC, Prestige Consumer Healthcare Inc, and Jamjoom Pharmaceuticals.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global eye drops market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global eye drops market

Market Segmentation

• Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Prescription Eye Drops
  • Over-the-Counter (OTC) Eye Drops
• Therapeutic Application Insights (Revenue, USD Bn, 2020 - 2032)
  • Dry Eye Disease (DED) Management
  • Allergic Conjunctivitis Treatment
  • Glaucoma & Ocular Hypertension
  • Eye Infection Treatment (Bacterial, Viral, Fungal)
  • Inflammation or Post-Surgical Care
  • Mydriasis or Cycloplegia
  • Diagnostic Dye Solutions
  • Post-Operative Care (Anesthetic Drops)
  • Uveitis
  • Other Retinal Disorders
• Drug Class Insights (Revenue, USD Bn, 2020 - 2032)
  • Lubricants and Emollients
  • Antihistamines
  • Mast Cell Stabilizers
  • Corticosteroids
  • Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Prostaglandin Analogs
  • Beta-Blockers
  • Alpha Agonists
  • Carbonic Anhydrase Inhibitors
  • Antibiotics
  • Antivirals
  • Antifungals
  • Vasoconstrictors
  • Combination Drugs
• Preservative Status Insights (Revenue, USD Bn, 2020 - 2032)
  • Preserved Eye Drops
  • Preservative-Free Eye Drops
• Type Insights (Revenue, USD Bn, 2020 - 2032)
  • Brand
  • Generics
• Formulation Insights (Revenue, USD Bn, 2020 - 2032)
  • Solution
  • Suspension
  • Emulsion
• Viscosity Insights (Revenue, USD Bn, 2020 - 2032)
  • Low Viscosity
  • Medium Viscosity
  • High Viscosity
• Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• End User Insights (Revenue, USD Bn, 2020 - 2032)
  • Hospitals
  • Ophthalmology Clinics
  • Others (Ambulatory Surgery Centers)
• Regional Insights (Revenue, USD Bn, 2020 - 2032)
  • North America
  • U.S.
  • Canada
  • Latin America
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Europe
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
  • South Africa
  • North Africa
  • Central Africa
• Key Players Insights
  • Alcon
  • AbbVie Inc (Allergan)
  • Bausch Health Companies Inc
  • Johnson & Johnson Vision
  • Santen Pharmaceutical Co Ltd
  • Pfizer Inc
  • Bayer AG
  • Sun Pharmaceutical Industries Ltd
  • Otsuka Pharmaceutical Co Ltd
  • Rohto Pharmaceutical Co Ltd
  • Thea Pharma Inc
  • Similasan Corporation
  • Akorn Operating Company LLC
  • Prestige Consumer Healthcare Inc
  • Jamjoom Pharmaceuticals

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Global Eye Drops Market, By Type
  • Global Eye Drops Market, By Therapeutic Application
  • Global Eye Drops Market, By Drug Class
  • Global Eye Drops Market, By Preservative Status
  • Global Eye Drops Market, By Type
  • Global Eye Drops Market, By Formulation
  • Global Eye Drops Market, By Viscosity
  • Global Eye Drops Market, By Distribution Channel
  • Global Eye Drops Market, By End User
  • Global Eye Drops Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Driver
• Restraint
• Opportunity
• Impact Analysis
• Key Developments
• Regulatory Scenario
• Product Launches/Approvals
• PEST Analysis
• PORTER's Analysis
• Merger and Acquisition Scenario
• Industry Trends

4. Global Eye Drops Market, By Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Prescription Eye Drops
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Over-the-Counter (OTC) Eye Drops
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

5. Global Eye Drops Market, By Therapeutic Application, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Dry Eye Disease (DED) Management
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Allergic Conjunctivitis Treatment
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Glaucoma & Ocular Hypertension
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Eye Infection Treatment (Bacterial, Viral, Fungal)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Inflammation or Post-Surgical Care
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mydriasis or Cycloplegia
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Diagnostic Dye Solutions
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Post-Operative Care (Anesthetic Drops)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Uveitis
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Other Retinal Disorders
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Eye Drops Market, By Drug Class, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Lubricants and Emollients
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Antihistamines
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Mast Cell Stabilizers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Corticosteroids
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Prostaglandin Analogs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Beta-Blockers
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Alpha Agonists
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Carbonic Anhydrase Inhibitors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Antibiotics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Antivirals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Antifungals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Vasoconstrictors
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Combination Drugs
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Eye Drops Market, By Preservative Status, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Preserved Eye Drops
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Preservative-Free Eye Drops
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Eye Drops Market, By Type, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Brand
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Generics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

9. Global Eye Drops Market, By Formulation, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Solution
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Suspension
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Emulsion
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

10. Global Eye Drops Market, By Viscosity, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Low Viscosity
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Medium Viscosity
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• High Viscosity
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

11. Global Eye Drops Market, By Distribution Channel, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospital Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Retail Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Online Pharmacies
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

12. Global Eye Drops Market, By End User, 2020-2032, (USD Bn)

• Introduction
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2021 - 2032
  • Segment Trends
• Hospitals
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Ophthalmology Clinics
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
• Others (Ambulatory Surgery Centers)
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

13. Global Eye Drops Market, By Region, 2020 - 2032, Value (USD Bn)

• Introduction
  • Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
  • Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • U.S.
    • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • Germany
    • U.K.
    • Spain
    • France
    • Italy
    • Russia
    • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
    • GCC Countries
    • Israel
    • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Therapeutic Application, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Drug Class, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Preservative Status, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Formulation, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Viscosity, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
  • Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
    • South Africa
    • North Africa
    • Central Africa

14. Competitive Landscape

• Alcon
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• AbbVie Inc (Allergan)
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bausch Health Companies Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Johnson & Johnson Vision
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Santen Pharmaceutical Co Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Pfizer Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Bayer AG
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Sun Pharmaceutical Industries Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Otsuka Pharmaceutical Co Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Rohto Pharmaceutical Co Ltd
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Thea Pharma Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Similasan Corporation
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Akorn Operating Company LLC
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Prestige Consumer Healthcare Inc
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
• Jamjoom Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

15. Analyst Recommendations

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

16. References and Research Methodology

• References
• Research Methodology
• About us